The Mandalorian and Grogu topped the Memorial Day weekend box office with $82 million domestically and $165 million globally, which sounds impressive until you realize it's basically tracking with Solo: A Star Wars Story - not exactly the comparison Disney was hoping for.
But that's not really the story here. The story is Obsession, the mid-budget horror film that's doing something movies aren't supposed to do anymore: growing in its second weekend.
According to NBC News, Obsession saw a 30% uptick in ticket sales, earning $22.4 million in weekend two. Industry analyst Paul Dergarabedian called this trajectory "really unheard of," driven by social media buzz from younger viewers.
Let's put this in context: the film was acquired for around $15 million and is projected to hit $58.5 million domestically. That's not Avengers money, but it's genuine theatrical profitability - a concept that's become almost quaint in the era of $200 million blockbusters and straight-to-streaming dumps.
The conventional wisdom in Hollywood right now is that theatrical is only viable for massive event films and maybe the occasional Christopher Nolan prestige picture. Everything else should go to streaming, where it can be algorithmically served to subscribers and then deleted for tax purposes.
Obsession suggests that wisdom might be wrong. Or at least, incomplete.
Mid-budget theatrical releases used to be the industry's bread and butter - the $20-50 million films that weren't chasing Avatar numbers but could turn a healthy profit through theatrical runs, international sales, and eventual home video. That model collapsed when streaming became the default destination for anything that wasn't a guaranteed blockbuster.
But Obsession's success points to something studios have forgotten: if you make a competent genre film, don't overextend on the budget, and let word-of-mouth build, theatrical can still work. The 30% second-weekend increase isn't just unusual; it's proof that audiences will show up for something that isn't a franchise if it delivers on its genre promises.
Meanwhile, The Mandalorian and Grogu is performing fine but not spectacularly. It cost $165 million to produce, which is substantially less than Solo's bloated $300 million budget, so profitability is achievable. But for Star Wars, "fine" feels like a disappointment. The franchise that used to print money is now just... a solid performer.
The question is whether Obsession represents an anomaly or a trend. Is this a one-off success, or proof that the theatrical market still has room for mid-budget films that deliver? If studios were smart - and in Hollywood, nobody knows anything - they'd be studying this closely.
Because if horror films with modest budgets can still find theatrical audiences through word-of-mouth, maybe the future isn't just $200 million blockbusters and streaming filler. Maybe there's still a middle ground.
Now the question is: will anyone actually learn this lesson, or will next quarter's earnings call wipe this data from executive memory?
In Hollywood, nobody knows anything - except that betting against genre fans is usually a mistake.
